首页> 外国专利> Inhibitor of human myeloid leukemia HL-60 cells based on bisN-(prop-2-en-1-yl)-2-(pyridine-2-ylmethylidene)hydrazinecarbothioamidenickel(II) chloride hydrate

Inhibitor of human myeloid leukemia HL-60 cells based on bisN-(prop-2-en-1-yl)-2-(pyridine-2-ylmethylidene)hydrazinecarbothioamidenickel(II) chloride hydrate

机译:基于双[N-(丙-2-烯-1-基)-2-(吡啶-2-基亚甲基)肼甲硫代氨基甲酰氨基]氯化镍(II)水合物的人骨髓白血病HL-60细胞抑制剂

摘要

The invention relates to chemistry, namely to a coordinative compound from the class of thiosemicarbazonates of transition metals and may find application in medicine for the prevention and treatment of human myeloid leukemia.Summary of the invention consists in that as an inhibitor of human myeloid leukemia HL-60 cells is proposed the new bis[N-(prop-2-en-1-yl)-2-(pyridine-2-ylmethylidene)hydrazinecarbothioamide]nickel(II) chloride hydrate compound of formula:The claimed compound expands the range of highly active inhibitors of human myeloid leukemia cells.
机译:本发明涉及化学,即过渡金属的硫代半氨基甲酸酯类的配位化合物,可以在预防和治疗人骨髓性白血病的药物中得到应用。发明内容本发明的概述在于作为人髓性白血病的抑制剂HL提出了新的双[N-(丙-2-烯-1-基)-2-(吡啶-2-基亚甲基)肼甲硫基酰胺]氯化镍(II)水合物的-60单元电池:要求保护的化合物扩大了范围人骨髓性白血病细胞的高效抑制剂的研究。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号